A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.
Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...
No. The icemaker stops working about every 3 months. It is so annoying. The water filter and air filters from Sub-Zero are $129 and apparently they recommend replacement every 3 months. LOL.
After hours: March 21 at 7:29:08 PM EDT Loading Chart for PXLW ...
Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback